- Home
- HRMY vs PLUG Comparison
HRMY vs PLUG Comparison
Compare HRMY & PLUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- PLUG
- Stock Information
- Founded
- HRMY 2017
- PLUG 1997
- Country
- HRMY United States
- PLUG United States
- Employees
- HRMY N/A
- PLUG N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- PLUG Industrial Machinery/Components
- Sector
- HRMY Health Care
- PLUG Energy
- Exchange
- HRMY Nasdaq
- PLUG Nasdaq
- Market Cap
- HRMY 2.0B
- PLUG 1.6B
- IPO Year
- HRMY 2020
- PLUG 1999
- Fundamental
- Price
- HRMY $32.16
- PLUG $1.47
- Analyst Decision
- HRMY Strong Buy
- PLUG Hold
- Analyst Count
- HRMY 9
- PLUG 16
- Target Price
- HRMY $54.22
- PLUG $1.76
- AVG Volume (30 Days)
- HRMY 609.1K
- PLUG 101.9M
- Earning Date
- HRMY 08-05-2025
- PLUG 08-07-2025
- Dividend Yield
- HRMY N/A
- PLUG N/A
- EPS Growth
- HRMY 13.13
- PLUG N/A
- EPS
- HRMY 2.62
- PLUG N/A
- Revenue
- HRMY $744,852,000.00
- PLUG $642,224,000.00
- Revenue This Year
- HRMY $20.10
- PLUG $17.73
- Revenue Next Year
- HRMY $18.01
- PLUG $26.15
- P/E Ratio
- HRMY $12.27
- PLUG N/A
- Revenue Growth
- HRMY 20.62
- PLUG N/A
- 52 Week Low
- HRMY $26.47
- PLUG $0.69
- 52 Week High
- HRMY $41.61
- PLUG $3.34
- Technical
- Relative Strength Index (RSI)
- HRMY 43.25
- PLUG 63.92
- Support Level
- HRMY $31.70
- PLUG $1.09
- Resistance Level
- HRMY $33.69
- PLUG $1.57
- Average True Range (ATR)
- HRMY 0.89
- PLUG 0.14
- MACD
- HRMY -0.10
- PLUG 0.03
- Stochastic Oscillator
- HRMY 37.30
- PLUG 81.48
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.